Joshua Pinto, President at Neumora Therapeutics, Inc. (NMRA), sold 5,967 shares at $3.54 ($21K) on 2026-02-17, disclosed to the SEC on 2026-02-19.
Open-market sale of $21k NMRA by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NMRA | SELL | 2024-08-26 | $2.0M | — | Filing → |